Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Maud Flacelière
Observed names:
FLACELIERE, Maud,
Flacelière, Maud,
M. Flaceliere,
M. Flacelière,
Maud Flaceliere
Observed institutions:
Centre National de la Recherche Scientifique,
Inserm,
Université de Montpellier,
Institut de Génomique Fonctionnelle,
Université Montpellier 2
OpenAlex ID:
A5086640355
Essential requirement for β-arrestin2 in mouse intestinal tumors with elevated Wnt signaling
2012
·
Caroline Bonnans
, Maud Flacelière
, et al.
·
Proceedings of the National Academy of Sciences
·
50
Targeting the Wnt Pathway and Cancer Stem Cells with Anti-progastrin Humanized Antibodies as a Potential Treatment for K-RAS-Mutated Colorectal Cancer
2017
·
Alexandre Prieur
, Monica Cappellini
, et al.
·
Clinical Cancer Research
·
42
The oncogenic and druggable hPG80 (Progastrin) is overexpressed in multiple cancers and detected in the blood of patients
2019
·
Benoit You
, Frédéric Mercier
, et al.
·
EBioMedicine
·
21
PDF
A novel method to detect hPG 80 (human circulating progastrin) in the blood
2021
·
Monica Cappellini
, Maud Flaceliere
, et al.
·
Analytical Methods
·
9
PDF
Progastrin, a new blood biomarker for the diagnostic and therapeutic monitoring, in gastro-intestinal cancers: A BIG-RENAPE project
2018
·
B. You
, V. Kepenekian
, et al.
·
Annals of Oncology
·
2
Progastrin, a New Blood Biomarker for Multiple Cancers Allowing a New Strategy for Screening, Early Detection and Monitoring
2018
·
A. Prieur
, V. Kepenekian
, et al.
·
Journal of Global Oncology
·
1
supplementary methods from Targeting the Wnt Pathway and Cancer Stem Cells with Anti-progastrin Humanized Antibodies as a Potential Treatment for K-RAS-Mutated Colorectal Cancer
2023
·
Alexandre Prieur
, Monica Cappellini
, et al.
PDF
supplementary figures 1 to 13 and supplementary tables 1 to 4 from Targeting the Wnt Pathway and Cancer Stem Cells with Anti-progastrin Humanized Antibodies as a Potential Treatment for K-RAS-Mutated Colorectal Cancer
2023
·
Alexandre Prieur
, Monica Cappellini
, et al.
supplementary figures 1 to 13 and supplementary tables 1 to 4 from Targeting the Wnt Pathway and Cancer Stem Cells with Anti-progastrin Humanized Antibodies as a Potential Treatment for K-RAS-Mutated Colorectal Cancer
2023
·
Alexandre Prieur
, Monica Cappellini
, et al.
PDF
supplementary methods from Targeting the Wnt Pathway and Cancer Stem Cells with Anti-progastrin Humanized Antibodies as a Potential Treatment for K-RAS-Mutated Colorectal Cancer
2023
·
Alexandre Prieur
, Monica Cappellini
, et al.
Data from Targeting the Wnt Pathway and Cancer Stem Cells with Anti-progastrin Humanized Antibodies as a Potential Treatment for K-RAS-Mutated Colorectal Cancer
2023
·
Alexandre Prieur
, Monica Cappellini
, et al.
Data from Targeting the Wnt Pathway and Cancer Stem Cells with Anti-progastrin Humanized Antibodies as a Potential Treatment for K-RAS-Mutated Colorectal Cancer
2023
·
Alexandre Prieur
, Monica Cappellini
, et al.
Progastrin, a novel ubiquitous cancer blood biomarker for early detection and monitoring.
2019
·
Benoit You
, Eric Assenat
, et al.
·
Journal of Clinical Oncology
La β-arrestine2, un acteur majeur de la tumorigenèse intestinale dépendante de la voie Wnt/β-caténine.
2012
·
Maud Flacelière
Show more works
View as search
Works count:
16
Citation count:
125
H-index:
4
I10-index:
3
Year
Topic
Type